Clinical Trial Update: Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a conditioning regimen of gemcitabine, busulfan, and melphalan with hematopoietic cell transplantation for advanced lymphoid malignanci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• BUSULFAN (Busulfan)
• Gemcitabine (Gemcitabine)
• Melphalan (Melphalan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED